摘要
目的研究依拉达奉联合尿激酶静脉溶栓对急性脑梗死患者的临床疗效。方法选取急性脑梗死患者80例,按照随机数表法将其分为研究组和对照组,每组40例。对照组给予尿激酶静脉溶栓治疗,研究组在对照组的基础上联用依拉达奉进行治疗。对比两组患者治疗前、治疗1周、2周、3周后的神经缺损情况以、日常生活能力及治疗总有效率。结果治疗1周、2周、3周后,两组的神经功能缺损情况均有所改善,生活能力均有所提升,研究组的改善和提升程度均明显高于对照组(P<0.05)。两组治疗总有效率比较,P<0.05。结论将依拉达奉与尿激酶静脉溶栓联合用于治疗急性脑梗死患者,不仅可改善患者的神经功能,还可以提高患者的生活能力,治疗效果较为理想。
Objective To study the clinical efficacy of irradiin combined with urokinase intravenous thrombolysis in patients with acute cerebral infarction. Methods Eighty patients with acute cerebral infarction were enrolled and divided into study group and control group according to random number table method, 40 cases in each group. The control group was given intravenous thrombolytic therapy with urokinase, and the study group was treated with edaradine on the basis of the control group. The neurological deficits, daily living ability and total effective rate of treatment were compared before treatment, 1 week, 2 weeks and 3 weeks after treatment. Results After 1 week, 2 weeks and 3 weeks of treatment, the neurological deficits of both groups were improved, and the living ability was improved. The improvement and improvement of the study group were significantly higher than the control group (P<0.05). The total effective rate of the two groups was compared, P<0.05. Conclusion The combination of edaradine and urokinase in the treatment of acute cerebral infarction can not only improve the neurological function of patients, but also improve the patient's ability to live. The therapeutic effect is ideal.
作者
马建永
Ma Jianyong(Zhengzhou Yihe Hospital,Zhengzhou 450047,Henan)
出处
《菏泽医学专科学校学报》
2018年第4期37-39,67,共4页
Journal of Heze Medical College
